<VariationArchive VariationID="6371" VariationName="NM_003664.5(AP3B1):c.1168_1230del (p.Leu390_Gln410del)" VariationType="Deletion" Accession="VCV000006371" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2019-10-02" MostRecentSubmission="2019-10-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21410" VariationID="6371">
      <GeneList>
        <Gene Symbol="AP3B1" FullName="adaptor related protein complex 3 subunit beta 1" GeneID="8546" HGNC_ID="HGNC:566" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>5q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="78000522" stop="78294698" display_start="78000522" display_stop="78294698" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="77298149" stop="77590527" display_start="77298149" display_stop="77590527" Strand="-" />
          </Location>
          <OMIM>603401</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003664.5(AP3B1):c.1168_1230del (p.Leu390_Gln410del)</Name>
      <VariantType>Deletion</VariantType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003664.3" sequenceAccession="NM_003664" sequenceVersion="3" change="c.1168_1230del">
            <Expression>NM_003664.3:c.1168_1230del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003655.3" sequenceVersion="3" change="p.Leu390_Gln410del">
            <Expression>NP_003655.3:p.Leu390_Gln410del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="LRG_170p1" sequenceAccession="LRG_170p1" change="p.Leu390_Gln410del">
            <Expression>LRG_170p1:p.Leu390_Gln410del</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340560" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603401.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The paper by Dell'Angelica et al., 1999, (PubMed 1002487) analyzed the deletion only within cDNA.</Comment>
      <Comment DataSource="NCBI curation" Type="public">Evidence for this deletion was reviewed in Dell'Angelica et al., 1999, PubMed 1002487.  Only analyses of cDNA were found. Thus the genomic basis for this variant is uncertain.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003664.5(AP3B1):c.1168_1230del (p.Leu390_Gln410del) AND Hermansky-Pudlak syndrome 2" Accession="RCV000006743" Version="13">
        <ClassifiedConditionList TraitSetID="1768">
          <ClassifiedCondition DB="MedGen" ID="C1842362">Hermansky-Pudlak syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1999-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-10-02" MostRecentSubmission="2019-10-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10024875</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1768" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2034" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome 2</ElementValue>
                <XRef ID="MONDO:0011997" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Platelet defects and oculocutaneous albinism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS2</ElementValue>
                <XRef Type="MIM" ID="608233" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9435" />
                <XRef ID="9435" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15026" />
                <XRef ID="15026" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <XRef ID="183678" DB="Orphanet" />
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C1842362" DB="MedGen" />
              <XRef ID="MONDO:0011997" DB="MONDO" />
              <XRef Type="MIM" ID="608233" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26935" SubmissionDate="2019-09-30" DateLastUpdated="2019-10-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603401.0001_HERMANSKY-PUDLAK SYNDROME 2" title="AP3B1, 63-BP DEL_HERMANSKY-PUDLAK SYNDROME 2" />
        <ClinVarAccession Accession="SCV000026935" DateUpdated="2019-10-02" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Dell'Angelica et al. (1999) described a 63-bp deletion in 1 allele of the beta-3A-adaptin cDNA sequence in 2 affected members of a family with Hermansky-Pudlak syndrome-2 (HPS2; 608233). The other allele had a leu540-to-arg substitution (L540R; 603401.0002).</Attribute>
              <Citation>
                <ID Source="PubMed">10024875</ID>
              </Citation>
              <XRef DB="OMIM" ID="608233" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AP3B1" />
          </GeneList>
          <Name>AP3B1, 63-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">63-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603401.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HERMANSKY-PUDLAK SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26935" TraitType="Disease" MappingType="Name" MappingValue="HERMANSKY-PUDLAK SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C1842362" Name="Hermansky-Pudlak syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-12-10">SCV000041031</Accession>
        <Description>This variant is no longer cited in the GeneReview and has been deleted.</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

